Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults

Circulatory; Change Clinical Trial

Official title:
The Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults: a Randomised, Double-blind, Placebo-controlled Crossover Study

Status Not yet recruiting

Clinical Trial Summary

This is a randomized, double-blind, placebo-controlled, 2 arm crossover study conducted over 11 weeks, with participants randomised to a product for 4 weeks, followed by a 3-week washout period before completing the second product for 4 weeks, to study the effectiveness of a grape seed extract on circulatory measures in healthy adults.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Circulatory; Change

Clinical Trial Details

NCT number	NCT06440252
Study type	Interventional
Source	RDC Clinical Pty Ltd
Contact	Amanda Rao, PhD
Phone	+61 414 488 559
Email	amanda@rdcglobal.com.au
Status	Not yet recruiting
Phase	Phase 3
Start date	June 30, 2024
Completion date	June 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01417754` - Changes in Breast 3D Ultrasound Measurements Using Toremifene	Phase 3
Completed	`NCT03371537` - Study of Hemodynamic Conditions Measured During Hepatectomy
Active, not recruiting	`NCT03563105` - Assessment of Circulatory Compromise With Ox-Imager Using a Vascular Occlusion Test Protocol	N/A
Completed	`NCT02727829` - The Assessment of Microcirculation in Brachial Plexus Block Using Perfusion Index and Capillary Filling Time	N/A
Recruiting	`NCT05302219` - Plethysmography Curve Variability Depending on the Breath Cycle	N/A
Completed	`NCT03724162` - Evaluation of the Circulatory Status of Stomach Tube and Gastrooesophageal Anastomosis
Completed	`NCT03023488` - Effects of Flexible Ureteroscopy on Renal Blood Flow	N/A
Not yet recruiting	`NCT04630704` - Evaluating A Non-Invasive Tissue Perfusion Monitor